Shalom Zwiebel: Clinical Practice Evaluating PRP Systems and Supply Partners
Shalom Zwiebel, Clinical Liaison at Renova Wound Care, shared a post on LinkedIn:
“Clinical Practice Evaluating PRP Systems and Supply Partners
As the use of Platelet-Rich Plasma therapy (PRP) continues to expand across wound care, orthopedics, dermatology, and regenerative medicine, the consistency and reliability of PRP preparation systems are essential for achieving predictable clinical outcomes.
Our clinical practice is currently evaluating PRP technologies and supply partners to support ongoing and growing clinical utilization of biologic therapies in patient care.
We are interested in connecting with established manufacturers or authorized distributors that offer:
- Clinically validated PRP preparation systems
- Regulatory-compliant kits and centrifuge platforms
- Consistent platelet concentration and reproducible processing
- Reliable supply chain and clinical support for physician practices
Given the expected clinical volume, we are particularly interested in working with experienced U.S.-based manufacturers or distributors that can support long-term clinical partnerships.
If your organization manufactures or distributes PRP systems, kits, centrifuges, or regenerative medicine technologies, we would welcome the opportunity to learn more about your platform.
Manufacturers or authorized distributors only, please.
Please feel free to reach out via direct message or comment below.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke